The correlation analysis of 45 immune stimulators (Figure S7) revealed a negative correlation of EPHX2 expression with ULBP1 and TNFRSF8 in UVM, CD276 in PAAD, and CD276 in SARC. Here, CD276 is linked to pancreatic adenocarcinoma.